Merdad Parsey - 10 Sep 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Medical Officer
Signature
/s/ Edward S. Son by Power of Attorney for Merdad Parsey
Issuer symbol
GILD
Transactions as of
10 Sep 2023
Net transactions value
-$97,128
Form type
4
Filing time
11 Sep 2023, 20:19:06 UTC
Previous filing
20 Jul 2023
Next filing
13 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +2,779 +4% 72,909 10 Sep 2023 Direct F1
transaction GILD Common Stock Tax liability $97,128 -1,278 -1.8% $76.00 71,631 10 Sep 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -2,779 -6% 43,754 10 Sep 2023 Common Stock 2,779 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.